Company intelligence / Profile preview

Bios-Therapy

Ownership: Private
Development stage: Commercial

Overview

Bios Therapeutics is a next-generation pharmaceutical organization specializing in rare diseases. The company provides services and solutions for geographical expansion of small and mid-size pharma/biotech companies, acting as their local or regional representative—especially across EEC & Baltic regions, Greece, Cyprus & Malta. It does not appear to develop its own therapeutics but enables market access for innovative treatments from partner companies through flexible business models driven by experienced leadership in rare disease markets.

Therapeutic areas: Rare Diseases
Industry: Consulting

Partnerships

Key partnerships are implied with small/mid-size pharma and biotechs seeking geographic expansion into EEC/Baltic/Greece/Cyprus/Malta regions but no specific names are provided.

Beyond the preview

Go deeper on Bios-Therapy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bios-Therapy.

Explore the full profile